medications in patients with severe SLE would merit review by the treating rheumatologist in consideration of surgery. The Voting Panel agreed with their inclusion via email voting. This guideline is informed by cohort studies including pharmacoepidemiologic studies using large administrative databases. To our knowledge, there have been no randomized controlled trials since the publication of the prior ACR/AAHKS guideline in 2017, so much of the data supporting these recommendations remains